They Are Getting Closer To The Truth

[Guest guest]

This medical journal article, just published, comes closest to the recognition

of the truth that we have all known for years. Before you read the full article,

(Link Below), remember that Columbus thought that he had landed in

INDIA, when he got here. Only later, did others realize that he had discovered

a  " new world " . These British and Brazilian researchers have recognized the

importance of mold in causing illness. Naturally, they think that they have

found a new part of " INDIA " (Asthma). They have labeled this new part of

" INDIA " , as " SEVERE ASTHMA WITH FUNGAL SENSITIZATION (SAFS). They, or those who

follow them, will soon realize that they have discovered a whole " new world " .

This is the world that WE live in, called " TOXIC MOLD REACTION " .

 

When you read the full article, look at the " Discussion Section " , which says:

" Severe asthma seems to be strongly associated with atopy, especially to mould

allergens " . Their consensus that anti-fungal medicines should be used for

" SAFS " , will make tens of thousands of allergists and pulmonologists focus their

attention on mold.

 

We are much closer to seeing a medical, and legal, recognition of " our

reality " , than we have ever been. Naturally, you can expect OUR country to be

the absolute last country to recognize the truth.

 

Joe

.................................................................................\

....

  This is the abstract. Link to full article is at the end.

 

 

Background and objective:  Very little is known about the response rates to or

appropriateness of treatment for patients with allergic fungal diseases of the

lung. This study assessed the effect of antifungal therapy in patients with

severe asthma with fungal sensitization (SAFS) and allergic bronchopulmonary

aspergillosis (ABPA).

Methods:  A retrospective cohort study of 33 adult patients who fulfilled the

criteria for either SAFS (n = 22) or ABPA (n = 11) was conducted. All patients

had received antifungal therapy for at least 6 months. The primary study end

point was the effect of antifungal therapy on patients' lung function.

Results:  Overall, total IgE values and radioallergosorbent test (RAST) for A.

fumigatus markedly decreased after 6 months of therapy in both SAFS and ABPA

patients (P = 0.004 and P = 0.005, respectively). Reduction was seen in the

eosinophil count (P = 0.037), dose of oral steroids (P = 0.043) and courses of

systemic steroids required (P = 0.041). Lung function also improved (P = 0.016).

Four of 10 patients discontinued oral steroids after 6 months of therapy.

Reduction in IgE levels (P = 0.015) and RAST for A. fumigatus was also observed

(P = 0.006) for those patients treated for at least 1 year with antifungal

drugs.

Conclusions:  Both ABPA and SAFS patients benefited from oral antifungal

therapy. The antifungal therapy may act by reducing the antigenic load,

interacting with corticosteroids or by a direct immunological effect.

 

Click Link Below, To read Complete Article:

http://tinyurl.com/yz3zond